| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(96)00101-6 |
| P698 | PubMed publication ID | 9041669 |
| P2093 | author name string | R R Deck | |
| M A Liu | |||
| J B Ulmer | |||
| J J Donnelly | |||
| C M DeWitt | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| P304 | page(s) | 71-78 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine | |
| P478 | volume | 15 |
| Q42274080 | A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge |
| Q46030305 | A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver. |
| Q33409110 | A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice |
| Q30388514 | Advances in novel influenza vaccines: a patent review |
| Q30405461 | An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1. |
| Q44434155 | Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus |
| Q34080692 | Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease |
| Q45730050 | Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase. |
| Q34430856 | Atopic disorders: a vaccine around the corner? |
| Q77122487 | Characterization of humoral immune responses induced by immunization with plasmid DNA expressing HIV-1 Nef accessory protein |
| Q30410003 | Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection |
| Q39642529 | Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. |
| Q35620710 | Construction of a catsper1 DNA vaccine and its antifertility effect on male mice |
| Q45741835 | Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. |
| Q33783789 | DNA and RNA-based vaccines: principles, progress and prospects |
| Q38305815 | DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC). |
| Q42796006 | DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins |
| Q52917145 | DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses. |
| Q47830096 | DNA increases the potency of vaccination against infectious diseases. |
| Q33912001 | DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza |
| Q41604739 | DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors |
| Q39930573 | DNA vaccination with a mutated p53 allele induces specific cytolytic T cells and protects against tumor cell growth and the formation of metastasis |
| Q36226793 | DNA vaccine |
| Q93903589 | DNA vaccines |
| Q33923010 | DNA vaccines for viral infections: basic studies and applications |
| Q33765876 | DNA vaccines: a review |
| Q33537293 | DNA vaccines: technology and application as anti-parasite and anti-microbial agents |
| Q78164037 | DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection |
| Q81295487 | Dissecting the components of the humoral immune response elicited by DNA vaccines |
| Q46963372 | Enhancement of DNA vaccine potency using conventional aluminum adjuvants |
| Q81186770 | Epidermal DNA vaccine for influenza is immunogenic in humans |
| Q40788835 | Features of the antibody response attributable to plasmid backbone adjuvanticity after DNA immunization. |
| Q33591476 | Genetic vaccines |
| Q45887207 | HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinations |
| Q45750780 | IL-6 induces long-term protective immunity against a lethal challenge of influenza virus |
| Q46087169 | Immune responses induced in HHD mice by multiepitope HIV vaccine based on cryptic epitope modification |
| Q45737947 | Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting |
| Q39548701 | Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection |
| Q44165822 | Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus |
| Q73890482 | Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses |
| Q45750778 | Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice |
| Q46832650 | Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis |
| Q34731432 | Influenza DNA vaccines |
| Q74585996 | Intradermal DNA immunization by using jet-injectors in mice and monkeys |
| Q35023493 | New technology platforms in the development of vaccines for the future |
| Q44280990 | Nucleocapsid of rabies virus improve immune response of an inactivated avian influenza vaccine |
| Q77735521 | Potential for plasmid DNAs as vaccines for the new millennium |
| Q33731344 | Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines |
| Q40500253 | Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence |
| Q45738887 | Protection against influenza B virus infection by immunization with DNA vaccines. |
| Q38492551 | Protection against influenza virus challenge by topical application of influenza DNA vaccine |
| Q45456530 | Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation |
| Q33785071 | Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA |
| Q45437059 | Protective effects of a DNA vaccine expressing the infectious salmon anemia virus hemagglutinin-esterase in Atlantic salmon. |
| Q40800792 | Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene |
| Q33850246 | Recombinant Newcastle disease virus as a vaccine vector |
| Q34001129 | Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen |
| Q43504123 | Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responses |
| Q43739148 | Specificity of anti-Nef antibodies produced in mice immunized with DNA encoding the HIV-1 nef gene product. |
| Q40571417 | Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus |
| Q40358732 | The Toll-like receptor adaptor molecule TRIF enhances DNA vaccination against classical swine fever |
| Q45728663 | The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36 |
| Q43176824 | Transcutaneous immunization with inactivated influenza virus induces protective immune responses |
| Q78848846 | Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases |
| Q36380692 | Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major |
Search more.